Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
Go back to Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale| (NASDAQ: INDV) | Delayed: 34.88 -0.81 (2.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.69 | 52 Week High | $ | |||
| Open | $35.59 | 52 Week Low | $ | |||
| Day High | $35.62 | P/E | N/A | |||
| Day Low | $34.59 | EPS | $ | |||
| Volume | 4,684,170 | |||||
| SUPERNUS PHARM (NASDAQ: SUPN) | Delayed: 42.00 -0.92 (2.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.92 | 52 Week High | $26.84 | |||
| Open | $42.89 | 52 Week Low | $9.51 | |||
| Day High | $42.89 | P/E | N/A | |||
| Day Low | $41.60 | EPS | $-2.62 | |||
| Volume | 1,182,919 | |||||
